Your browser doesn't support javascript.
loading
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Callens, Céline; Driouch, Keltouma; Boulai, Anaïs; Tariq, Zakia; Comte, Aurélie; Berger, Frédérique; Belin, Lisa; Bièche, Ivan; Servois, Vincent; Legoix, Patricia; Bernard, Virginie; Baulande, Sylvain; Chemlali, Walid; Bidard, François-Clément; Fourchotte, Virginie; Salomon, Anne Vincent-; Brain, Etienne; Lidereau, Rosette; Bachelot, Thomas; Saghatchian, Mahasti; Campone, Mario; Giacchetti, Sylvie; Zafrani, Brigitte Sigal; Cottu, Paul.
Afiliación
  • Callens C; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Driouch K; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Boulai A; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Tariq Z; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Comte A; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France.
  • Berger F; Department of Biostatistics, Institut Curie, Saint-Cloud, France.
  • Belin L; Department of Biostatistics, Institut Curie, Saint-Cloud, France.
  • Bièche I; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Servois V; Imaging Department, Institut Curie, PSL Research University, Paris, France.
  • Legoix P; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France.
  • Bernard V; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France.
  • Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, PSL Research University, Paris, France.
  • Chemlali W; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France.
  • Fourchotte V; Surgery Department, Institut Curie, Paris, France.
  • Salomon AV; Pathology and Tumor Biology Department, Institut Curie, PSL Research University, Paris, France.
  • Brain E; Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Lidereau R; Genetics Department, Institut Curie, PSL Research University, Paris, France.
  • Bachelot T; Centre Léon Bérard, Lyon, France.
  • Saghatchian M; Gustave Roussy Cancer Campus, Villejuif, France.
  • Campone M; Institut de Cancérologie de l'Ouest Nantes, Nantes, France.
  • Giacchetti S; Hôpital Saint Louis, Breast diseases center, Paris, France.
  • Zafrani BS; Pathology and Tumor Biology Department, Institut Curie, PSL Research University, Paris, France.
  • Cottu P; Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. paul.cottu@curie.fr.
Genome Med ; 13(1): 44, 2021 03 15.
Article en En | MEDLINE | ID: mdl-33722295

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article